Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells.
about
Immune responses to human cancer stem-like cells/cancer-initiating cellsCurrent approaches in identification and isolation of human renal cell carcinoma cancer stem cellsImmunotargeting of cancer stem cellsChemotherapy targeting cancer stem cellsSpecific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.Dnajb8, a Member of the Heat Shock Protein 40 Family Has a Role in the Tumor Initiation and Resistance to Docetaxel but Is Dispensable for Stress Response.Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.Down-regulation of HSP40 gene family following OCT4B1 suppression in human tumor cell lines.Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.Reduced cytosolic carboxypeptidase 6 (CCP6) level leads to accumulation of serum polyglutamylated DNAJC7 protein: A potential biomarker for renal cell carcinoma early detection.Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.Emerging roles and underlying molecular mechanisms of DNAJB6 in cancerPeptide vaccination therapy: Towards the next generation.Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.Proteins are potent biomarkers to detect colon cancer progression.Implication of chemo-resistant memory T cells for immune surveillance in patients with sarcoma receiving chemotherapy.Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.Cross-talk between cancer-initiating cells and immune cells: considerations for combination therapiesCellular stress induces cancer stem-like cells through expression of DNAJB8 by activation of HSF1.
P2860
Q26781794-419AC0B3-3A1D-4891-A9B4-3CDCD7D36C93Q26786047-F7DBFD4D-FB74-4116-B8B4-041E8B4380F6Q27014031-D1A6991A-E0D3-423D-B2C1-D3123D0E3B47Q28085377-9D460F9A-0D82-43B5-B128-E066C2B707FEQ34070374-F41EEB6A-D405-43FF-AF85-B6EB2B9F92CEQ35889884-2B105C28-81EE-4410-8F12-21E953EEED98Q36293822-D9113E38-0A7E-4A20-AF06-53FC7ECD987CQ36758240-264FF0AB-0D1C-40C2-BC8A-3F82909183A1Q36998205-0113F42E-36D2-45B8-B611-6AECD751ADCFQ37225556-B92534A5-AF0A-49A0-92E4-B6B20CAF4655Q38767392-32DC6FDC-C722-4AEA-931C-7AA427B7924EQ38859055-1159353D-90F1-4F2C-BB6C-33B2C477A4F0Q38902336-D61E1B62-ED39-43EC-AE4E-08C2815BF8F5Q39176046-EB1BEC2C-C8DC-43B4-B7C0-7AC5DD0E2554Q41456559-09EAB37E-FB69-4C27-A20E-E3E763665E34Q41595465-5568F40E-3FA4-47CF-9BB1-D40E29A8B618Q42137660-13E0F987-5398-4A8A-9BE5-764E36E731A7Q42370340-B030CE6B-4BE6-4254-84BA-23D6B68438E5Q47217802-35D92282-22AF-428A-92F1-6516519913D8
P2860
Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Heat shock protein DNAJB8 is a ...... colon cancer-initiating cells.
@ast
Heat shock protein DNAJB8 is a ...... colon cancer-initiating cells.
@en
type
label
Heat shock protein DNAJB8 is a ...... colon cancer-initiating cells.
@ast
Heat shock protein DNAJB8 is a ...... colon cancer-initiating cells.
@en
prefLabel
Heat shock protein DNAJB8 is a ...... colon cancer-initiating cells.
@ast
Heat shock protein DNAJB8 is a ...... colon cancer-initiating cells.
@en
P2093
P2860
P356
P1433
P1476
Heat shock protein DNAJB8 is a ...... colon cancer-initiating cells.
@en
P2093
Akari Takahashi
Masahiro Asaka
Noriyuki Sato
Rena Morita
Satoshi Hashino
Satoshi Nishizawa
Takayuki Kanaseki
Tomohide Tsukahara
Toru Kondo
P2860
P304
P356
10.1111/CAS.12362
P577
2014-02-24T00:00:00Z